Magnetic Resonance Elastography in the Diagnosis of Hepatic Fibrosis

Seminars in Ultrasound, CT and MRI

Volumn 34, Issue 1, 2013, Pages 81-88

  Godfrey, Edmund M ^a   Mannelli, Lorenzo ^b   Griffin, Nyree ^c   Lomas, David J ^d  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; GADOFOSVESET; PHOSPHORUS 31;

AREA UNDER THE CURVE; ARTICLE; CONTRAST ENHANCED ULTRASOUND; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ECHOGRAPHY; ELASTOGRAPHY; FATTY LIVER; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MAGNETIC RESONANCE ELASTOGRAPHY; MEDICAL LITERATURE; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PIEZOELECTRICITY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RECEIVER OPERATING CHARACTERISTIC; SUSCEPTIBILITY WEIGHTED IMAGING; ULTRASOUND ELASTOGRAPHY; ULTRASOUND SCANNER; VISCOELASTICITY;

BIOPSY; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING;

EID: 84873507471     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2012.11.007     Document Type: Article

References (72)

1. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.
2. Friedman S.L., Bansal M.B. Reversal of hepatic fibrosis-Fact or fantasy?. Hepatology 2006, 43:S82-S88.
3. Rockey D.C., Caldwell S.H., Goodman Z.D., et al. Liver biopsy. Hepatology 2009, 49:1017-1044.
4. Bonekamp S., Kamel I., Solga S., et al. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?. J Hepatol 2009, 50:17-35.
5. Poynard T., de Ledinghen V., Zarski J.P., et al. Relative performances of FibroTest, fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard. J Hepatol 2011, 56:541-548.
6. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97:2614-2618.
7. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. N Engl J Med 2001, 344:495-500.
8. Hepatology 1994, 20:15-20.
9. Weigand K. Percutaneous liver biopsy: Retrospective study over 15 years comparing 287 inpatients with 428 outpatients. J Gastroenterol Hepatol 2009, 24:792-799.
10. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
11. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
12. Goodman Z.D. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 2007, 47:598-607.
13. Asbach P., Klatt D., Schlosser B., et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 2010, 257:80-86.
14. Wang Y., Ganger D.R., Levitsky J., et al. Assessment of chronic hepatitis and fibrosis: Comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011, 196:553-561.
15. Yin M., Talwalkar J.A., Glaser K.J., et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007, 5:1207-1213. [e2].
16. Carrion J.A., Navasa M., Forns X. MR elastography to assess liver fibrosis. Radiology 2008, 247:591. [author reply-2].
17. Huwart L., Sempoux C., Salameh N., et al. Liver fibrosis: Noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007, 245:458-466.
18. Huwart L., Sempoux C., Vicaut E., et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008, 135:32-40.
19. O'Brien M.J., Keating N.M., Elderiny S., et al. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 2000, 114:712-718.
20. Pilette C., Rousselet M.C., Bedossa P., et al. Histopathological evaluation of liver fibrosis: Quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol 1998, 28:439-446.
21. Friedenberg M.A., Miller L., Chung C.Y., et al. Simplified method of hepatic fibrosis quantification: Design of a new morphometric analysis application. Liver Int 2005, 25:1156-1161.
22. Goodman Z.D., Becker R.L., Pockros P.J., et al. Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis. Hepatology 2007, 45:886-894.
23. Lazzarini A.L., Levine R.A., Ploutz-Snyder R.J., et al. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int 2005, 25:1142-1149.
24. Calvaruso V., Burroughs A.K., Standish R., et al. Computer-assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology 2009, 49:1236-1244.
25. Muthupillai R., Lomas D.J., Rossman P.J., et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 1995, 269:1854-1857.
26. Mariappan Y.K., Glaser K.J., Ehman R.L. Magnetic resonance elastography: A review. Clin Anat 2010, 23:497-511.
27. Asbach P., Klatt D., Hamhaber U., et al. Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 2008, 60:373-379.
28. Huwart L., Peeters F., Sinkus R., et al. Liver fibrosis: Non-invasive assessment with MR elastography. NMR Biomed 2006, 19:173-179.
29. Huwart L., Salameh N., ter Beek L., et al. MR elastography of liver fibrosis: Preliminary results comparing spin-echo and echo-planar imaging. Eur Radiol 2008, 18:2535-2541.
30. Chen J., Talwalkar J.A., Yin M., et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011, 259:749-756.
31. Rouviere O., Yin M., Dresner M.A., et al. MR elastography of the liver: Preliminary results. Radiology 2006, 240:440-448.
32. Yin M., Talwalkar J.A., Glaser K.J., et al. Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease. AJR Am J Roentgenol 2011, 197:64-70.
33. Motosugi U., Ichikawa T., Sou H., et al. Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. Magn Reson Imaging 2012, 30:128-132.
34. Venkatesh S.K., Yin M., Glockner J.F., et al. MR elastography of liver tumors: Preliminary results. AJR Am J Roentgenol 2008, 190:1534-1540.
35. Manduca A., Oliphant T.E., Dresner M.A., et al. Magnetic resonance elastography: Non-invasive mapping of tissue elasticity. Med Image Anal 2001, 5:237-254.
36. Salameh N., Peeters F., Sinkus R., et al. Hepatic viscoelastic parameters measured with MR elastography: Correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 2007, 26:956-962.
37. Yin M., Woollard J., Wang X., et al. Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 2007, 58:346-353.
38. Salameh N., Larrat B., Abarca-Quinones J., et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 2009, 253:90-97.
39. Wang Q.B., Zhu H., Liu H.L., et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology 2012, 56:239-247.
40. Warner L., Yin M., Glaser K.J., et al. Noninvasive in vivo assessment of renal tissue elasticity during graded renal ischemia using MR elastography. Invest Radiol 2011, 46:509-514.
41. Castera L., Bedossa P. How to assess liver fibrosis in chronic hepatitis C: Serum markers or transient elastography vs. liver biopsy?. Liver Int 2011, 31(suppl 1):13-17.
42. Baranova A., Lal P., Birerdinc A., et al. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol 2011, 11:91.
43. Halfon P., Munteanu M., Poynard T. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 2008, 32:22-39.
44. Friedrich-Rust M., Ong M.F., Martens S., et al. Performance of transient elastography for the staging of liver fibrosis: Ameta-analysis. Gastroenterology 2008, 134:960-974.
45. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
46. Friedrich-Rust M., Nierhoff J., Lupsor M., et al. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: A pooled meta-analysis. J Viral Hepat 2012, 19:e212-e219.
47. Colombo S., Buonocore M., Del Poggio A., et al. Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol 2012, 47:461-469.
48. Orlacchio A., Bolacchi F., Petrella M.C., et al. Liver contrast enhanced ultrasound perfusion imaging in the evaluation of chronic hepatitis C fibrosis: Preliminary results. Ultrasound Med Biol 2011, 37:1-6.
49. Sugimoto K., Shiraishi J., Moriyasu F., et al. Analysis of intrahepatic vascular morphological changes of chronic liver disease for assessment of liver fibrosis stages by micro-flow imaging with contrast-enhanced ultrasound: Preliminary experience. Eur Radiol 2010, 20:2749-2757.
50. Ronot M., Asselah T., Paradis V., et al. Liver fibrosis in chronic hepatitis C virus infection: Differentiating minimal from intermediate fibrosis with perfusion CT. Radiology 2010, 256:135-142.
51. Hagiwara M., Rusinek H., Lee V.S., et al. Advanced liver fibrosis: Diagnosis with 3D whole-liver perfusion MR imaging-Initial experience. Radiology 2008, 246:926-934.
52. Leporq B., Dumortier J., Pilleul F., et al. 3D-liver perfusion MRI with the MS-325 blood pool agent: A noninvasive protocol to asses liver fibrosis. J Magn Reson Imaging 2012, 35:1380-1387.
53. Noren B., Dahlqvist O., Lundberg P., et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur J Radiol 2008, 66:313-320.
54. Noren B., Lundberg P., Ressner M., et al. Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease. Eur Radiol 2005, 15:148-157.
55. Lim A.K., Patel N., Hamilton G., et al. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003, 37:788-794.
56. Corbin I.R., Ryner L.N., Singh H., et al. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol 2004, 287:G379-G384.
57. Dezortova M., Taimr P., Skoch A., et al. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J Gastroenterol 2005, 11:6926-6931.
58. Kiyono K., Shibata A., Sone S., et al. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy. Acta Radiol 1998, 39:309-314.
59. Menon D.K., Sargentoni J., Taylor-Robinson S.D., et al. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances. Hepatology 1995, 21:417-427.
60. Yudkin J.S., Lipska K.J., Montori V.M. The idolatry of the surrogate. Br Med J 2011, 343:d7995.
61. Everhart J.E., Wright E.C., Goodman Z.D., et al. Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2010, 51:585-594.
62. Binkovitz L.A., El-Youssef M., Glaser K.J., et al. Pediatric MR elastography of hepatic fibrosis: Principles, technique and early clinical experience. Pediatr Radiol 2012, 42:402-409.
63. Mannelli L., Godfrey E., Graves M.J., et al. Magnetic resonance elastography: Feasibility of liver stiffness measurements in healthy volunteers at 3T. Clin Radiol 2012, 67:258-262.
64. Watanabe H., Kanematsu M., Kitagawa T., et al. MR elastography of the liver at 3T with cine-tagging and bending energy analysis: Preliminary results. Eur Radiol 2010, 20:2381-2389.
65. Mannelli L., Godfrey E., Joubert I., et al. MR elastography: Spleen stiffness measurements in healthy volunteers-Preliminary experience. AJR Am J Roentgenol 2010, 195:387-392.
66. Arani A., Plewes D., Krieger A., et al. The feasibility of endorectal MR elastography for prostate cancer localization. Magn Reson Med 2011, 66:1649-1657.
67. Kolipaka A., Woodrum D., Araoz P.A., et al. MR elastography of the in vivo abdominal aorta: A feasibility study for comparing aortic stiffness between hypertensives and normotensives. J Magn Reson Imaging 2012, 35:582-586.
68. Kolipaka A., McGee K.P., Manduca A., et al. In vivo assessment of MR elastography-derived effective end-diastolic myocardial stiffness under different loading conditions. J Magn Reson Imaging 2011, 33:1224-1228.
69. Mariappan Y.K., Glaser K.J., Hubmayr R.D., et al. MR elastography of human lung parenchyma: Technical development, theoretical modeling and in vivo validation. J Magn Reson Imaging 2011, 33:1351-1361.
70. McKnight A.L., Kugel J.L., Rossman P.J., et al. MR elastography of breast cancer: Preliminary results. AJR Am J Roentgenol 2002, 178:1411-1417.
71. Dresner M.A., Rose G.H., Rossman P.J., et al. Magnetic resonance elastography of skeletal muscle. J Magn Reson Imaging 2001, 13:269-276.
72. Xu L., Lin Y., Xi Z.N., et al. Magnetic resonance elastography of the human brain: A preliminary study. Acta Radiol 2007, 48:112-115.